NLRP3 and atherosclerosis: CC are often used in the experimental setting of an acute treatment of cells and a major finding has been the activation of the NLRP3 inflammasome including a lysosome-related pathway and its subsequent impact on atherosclerosis development and progression.[20,69] However, we were unable to detect activation of the NLRP3 inflammasome in our study.